Outcomes of lobectomy on pulmonary function for early stage non‐small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD)

Feng Chen,Sen Wei,Bo Zhang,Renwang Liu,Dianxun Fu,D. Ren,Jun Chen,F. Ren,Song Xu,Zuoqing Song,Yanye Wang
DOI: https://doi.org/10.1111/1759-7714.13445
IF: 3.223
2020-05-06
Thoracic Cancer
Abstract:Lung cancer is the first cause of cancer mortality worldwide. Chronic obstructive pulmonary disease (COPD) is an independent risk factor for lung cancer. An epidemiological survey discovered that the presence of COPD increases the risk of lung cancer by 4.5‐fold. Lobectomy is considered to be the standard surgical method for early stage non‐small cell lung cancer (NSCLC). However, the influence of lobectomy on the loss of pulmonary function has not been fully investigated in NSCLC patients with COPD.
Medicine
What problem does this paper attempt to address?